Clinical Trials Browser

Phase 1/2 × Recruiting × Lymphoma, T-Cell, Peripheral × Clear all

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, T-Cell, Peripheral

NCT07523555 2026-04-13

ADAPT-HEM

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Blastic Plasmacytoid Dendritic Cell Neoplasm, Burkitt Lymphoma, Leukemia, Plasma Cell, Multiple Myeloma, Recurrence, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Lymphoma, T-Cell, Peripheral, Hematologic Neoplasms, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Clinical Trials

PRIMAVERA

ADAPT-HEM

Evaluate the Safety and Clinical Activity of HH2853

Study to Evaluate Efficacy and Safety of HH2853 in Relapsed/Refractory Peripheral T-cell Lymphoma

Golidocitinib Combined With Mitoxantrone Hydrochloride Liposome or Chidamide in the Treatment of Relapsed or Refractory Peripheral T-cell Lymphoma

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

Linperlisib Combined With Chidamide in Patients With PTCL

A Phase I/II Study of Golidocitinib Combined with Pomalidomide in R/R PTCL

Golidocitinib Plus CHOP in Newly Diagnosed PTCL

A Study of GFH009 Monotherapy in Patients with Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

Azacytidine Plus CAOLD Regimen in Relapsed/Refractory Peripheral T-Cell Lymphomas

Linperlisib in Combination With CHOP in Previously Untreated Peripheral T-Cell Lymphoma

A Study of SHR2554 With Chemotherapy in Treatment-naïve Patients With Peripheral T-cell Lymphoma

THEORY